Egypt. As a result, Egypt was declared polio-free by the WHO in
About M.P. Chumakov Institute of Poliomyelitis and Viral Encephalitides
The Institute of Poliomyelitis Research was established in 1955 by Michael Chumakov who became its first Director.
In 1960, the Institute included several laboratories and research departments from other research organizations and became Institute of Poliomyelitis and Viral Encephalitides.
Inactivated polio Salk vaccine has been produced in the Institute from 1956 to 1958, and since 1959 live attenuated polio vaccine administered orally (OPV) manufactured by the Institute has been used for mass vaccination campaigns.
Production technology of oral polio vaccine created in the Institute was the first to be certified by WHO for production and control of polio vaccines.
In the 1980's, new inactivated vaccine against tick-born encephalitis was developed by the Institute.
Now scientists are working on creation of human gamma immunoglobulin by new hybrid technology.
Vaccines against rabies and hepatitis A were also developed in research laboratories of M.P. Chumakov Institute and other Russian manufacturers produce those vaccines for mass vaccination.
The Institute has an exclusive advantage of close coordination between research and industrial operations. Scientists are involved in creating new vaccines and also new technologies for mass production.
The research department of M. P. Chumakov Institute includes 18 laboratories with 91 research scientists, including four academicians. The Institute produces live polio vaccine, vaccine against tick-born encephalitis, rabies, yellow fever, and measles.
Poliomyelitis (polio) is a highly infectious disease caused by a virus
that invades the nervous system and can cause severe paralysis. The virus
enters the body through
|SOURCE Sanofi Pasteur|
Copyright©2008 PR Newswire.
All rights reserved